From Silence To Seizures: Benzodiazepine-Induced Neonatal Abstinence Syndrome In A Preterm Newborn– A Rare Case From Darul Sehat Hospital.
DOI:
https://doi.org/10.36283/ziun-pjmd15-1/032Keywords:
Passive addiction, Abstinence syndrome, WithdrawalAbstract
This case report delves into the clinical presentation, examination and management of a neonate from Pakistan, diagnosed with NEONATAL ABSTINENCE SYNDROME(NAS) at DarulSehat. It’s a withdrawal condition affecting infants with opioids or other Central Nervous System depressants exposure in utero. The subject, born at 33 weeks via emergency C-section to a mother with history of opioid use exhibited classical symptoms of NAS including high pitched cry, hyperirritability, seizures, tachypnea, tremors-within 24 hours postpartum. Thorough clinical evaluation supported by laboratory and imaging findings led to diagnosis of NAS secondary to maternal benzodiazepine abuse during pregnancy. A Finnegan Neonatal Abstinence Scoring System was used to monitor the severity of withdrawal symptoms and guide treatment. This case accentuates importance of early identification, standardized assessment protocols and multidisciplinary approach of NAS to improve short and long term outcomes. It also emphasizes the ongoing need for support systems for families affected by this disorder.
References
1) Plouffe R, Grywacheski V, Luo W, Nelson C, Orpana H. Neonatal abstinence syndrome hospitalizations in Canada: a descriptive study. Canadian Journal of Public Health. 2022 Dec 8;
2)Armbruster D, Schwirian C, Mosier A, Tam WYM, Prusakov P. Neonatal Abstinence Syndrome and Preterm Infants. Advances in Neonatal Care. 2021 Mar 5;21(2):107–14.
3)Corr TE, Schaefer EW, Paul IM. Growth during the first year in infants affected by neonatal abstinence syndrome. BMC Pediatrics. 2018 Nov 5;18(1).
4)Google.com. 2022 [cited 2025 Jul 5]. Available from: https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.unodc.org/copak/en/PR/national-drug-use-survey-pakistan-2022-24--launched.html&ved=2ahUKEwiPzK_jhKaOAxX2xQIHHdT6AtsQFnoECBgQAQ&usg=AOvVaw0YvRnoXFlMNddEhmQOCSxV
5)Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, et al. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015 May 14;350(may14 1):h2102–2.
6)Sanlorenzo LA, Cooper WO, Dudley JA, Stratton S, Maalouf FI, Patrick SW. Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure. Hospital Pediatrics [Internet]. 2019 Jul 1;9(8):569–75. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663519/pdf/hpeds.2018-0227.pdf
7)Baldo BA. Neonatal opioid toxicity: opioid withdrawal (abstinence) syndrome with emphasis on pharmacogenomics and respiratory depression. Archives of Toxicology. 2023 Aug 3;97(10):2575–85.
8) Sarkar S, Donn SM. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Journal of Perinatology. 2005 Nov 24;26(1):15–7.
9) Palla MR, Khan G, Haghighat ZM, Bada H. EEG Findings in Infants With Neonatal Abstinence Syndrome Presenting With Clinical Seizures. Frontiers in Pediatrics [Internet]. 2019 Mar 29 [cited 2021 Jul 21];7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449643/
10)Zankl A, Martin J, Davey JG, Osborn DA. Sedatives for opioid withdrawal in newborn infants. Cochrane Database of Systematic Reviews. 2021 May 18;2021(5).
11)Allocco E, Melker M, Rojas-Miguez F, Bradley C, Hahn KA, Wachman EM. Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants. Advances in Neonatal Care. 2016 Oct;16(5):329–36.
12)Elliott MR, Cunliffe P, Demianczuk N, Robertson CMT. Frequency of Newborn Behaviours Associated with Neonatal Abstinence Syndrome: A Hospital-Based Study. Journal of Obstetrics and Gynaecology Canada. 2004 Jan;26(1):25–34.
13) Rice P. Neonatal Abstinence Syndrome and the Relationship Between Respiration and Feeding [Internet]. Digital Commons @ East Tennessee State University. 2020 [cited 2025 Jul 8]. Available from: https://dc.etsu.edu/etd/3711
14)Armbruster D, Schwirian C, Mosier A, Tam WYM, Prusakov P. Neonatal Abstinence Syndrome and Preterm Infants. Advances in Neonatal Care. 2021 Mar 5;21(2):107–14.
15)Davala S, Hansbury A, Miller M, Boateng J, Shrestha H, Wachman EM. Pilot Study Comparing Adverse Cardiorespiratory Events among Pharmacologically and Nonpharmacologically Treated Infants Undergoing Monitoring for Neonatal Abstinence Syndrome. The Journal of Pediatrics: X [Internet]. 2020 May 16;3:100027. Available from: https://www.sciencedirect.com/science/article/pii/S2590042020300082
16)Wachman EM, Schiff DM, Silverstein M. Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment. JAMA [Internet]. 2018;319(13):1362–74. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29614184
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
